Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02106871
What this trial is testing

Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer

Who this might be right for
Pancreatic CancerCholangiocarcinoma
The University of Texas Medical Branch, Galveston
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03699319
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
David Bajor, MD 49
Testing effectiveness (Phase 2)Study completedNCT03225989
What this trial is testing

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Who this might be right for
Pancreatic AdenocarcinomaOvarian CancerBiliary Carcinoma+1 more
Lokon Pharma AB 47
Testing effectiveness (Phase 2)Study completedNCT00617708
What this trial is testing

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Stage IV Pancreatic Cancer
National Cancer Institute (NCI) 134
Not applicableLooking for participantsNCT07651358
What this trial is testing

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Stage I Pancreatic Cancer AJCC v8Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT01234935
What this trial is testing

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more
Translational Oncology Research International 8
Early research (Phase 1)Looking for participantsNCT04222413
What this trial is testing

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Early research (Phase 1)Study completedNCT01897415
What this trial is testing

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Who this might be right for
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
University of Pennsylvania 16
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Early research (Phase 1)Ended earlyNCT02707328
What this trial is testing

Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)

Who this might be right for
Pancreas CancerPancreatic CancerAdenocarcinoma of the Pancreas+2 more
The Cooper Health System 30
Early research (Phase 1)Ended earlyNCT01086332
What this trial is testing

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Iowa 7
Early research (Phase 1)Study completedNCT01335958
What this trial is testing

Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Who this might be right for
Ovarian Cancer, Pancreatic Cancer
Genentech, Inc. 77
Testing effectiveness (Phase 2)Ended earlyNCT00003085
What this trial is testing

Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Southern California 28
Early research (Phase 1)Study completedNCT00703638
What this trial is testing

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 16
Not applicableUnknownNCT05227898
What this trial is testing

Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer

Who this might be right for
Cancer
Blue Note Therapeutics 352
Early research (Phase 1)Study completedNCT01832116
What this trial is testing

89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients

Who this might be right for
Ovarian NeoplasmsOvarian DiseasesAdnexal Diseases+4 more
University Medical Center Groningen 11
Early research (Phase 1)UnknownNCT02599662
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreas Cancer

Who this might be right for
Pancreas Cancer
Loyola University 12
Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Next Page